Keensight Capital completed the acquisition of a majority stake in BYG4lab.

Keensight Capital, a private equity manager, completed the acquisition of a majority stake in BYG4lab, a provider of data management software for medical laboratories. Financial terms were not disclosed. “Over the past 10 years, BYG4lab has become a leading player in its niche and is now ready to accelerate its growth by activating product diversification and geographic expansion. Keensight Capital’s investment is a significant signal of this new phase of our growth. Keensight team’s dual expertise in both Technology and Healthcare and its capacity to help us expand internationally will be great assets to bring the company to the next level,” Cyril Verhille BYG4lab CEO.